doi: 10.1038/s41598-017-15668-z 104 ZouYHenryWSRicqELGrahamETPhadnisVVMaretichPet al
Common gastrointestinal effects reported with GLP-1 therapy include: Nausea (commonly reported, especially during dose escalation) Constipation or diarrhoea Abdominal discomfort or bloating Reduced appetite and early satiety Regarding bowel movement colour specifically, changes in stool colour are not listed as adverse effects in UK SmPCs for GLP-1 receptor agonists
Glutathione, known as the bodys master antioxidant, is a tripeptide composed of three amino acids - cysteine, glycine, and glutamate
What supplements can support adrenal health
If you have been diagnosed with a thyroid condition, you must continue your medication as prescribed and consult your GP before making significant dietary changes
GLP-1 users need a new framework: intentional hydration micronutrient-dense meals foods that support gut health high-quality protein in smaller portions counselling to rebuild relationship with food GLP-1 is just a tool, not a replacement for nutrition
